Loading market dashboard
Novanta Inc.
NOVTTechnologyNASDAQUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
On May 22, 2026, Novanta Inc (NOVT) shares rose 3.1% to $159.70, reflecting a positive price movement amid a strong performance over the past month and year. Th
On May 20, 2026, Novanta Inc (NOVT) shares rose 4.0% today, bringing the current price to $153.60. The stock has experienced a 52-week range of $98.27 to $165.5
Novanta (NOVT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive.
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial orig.
Novanta Inc. (NOVT) Q1 2026 Earnings Call Transcript
Novanta NASDAQ: NOVT reported stronger-than-expected first-quarter 2026 results, with management citing broad-based bookings growth, accelerating demand in automation and medical markets, and rising exposure to artificial intelligence-related infrastructure applications.
Novanta (NOVT) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.74 per share a year ago.
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2026. Financial Highlights Three Months Ended (In millions, except per share amounts) April 3, March 28, 2026 2025 GAAP Revenue $ 257.7 $ 233.4 Operating Income $ 27.5 $ 32.4 Net Income $ 21.1 $ 21.2 Diluted EPS $ 0.51 $ 0.5.
On April 29, 2026, Novanta Inc (NOVT) shares fell 6.3% to $120.89. This decline comes amid a 52-week range of $98.27 to $149.95, reflecting notable volatility.
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2026 results after the close of U.S. financial markets on Monday, May 11, 2026. The Company will host a conference call on Tuesday, May 12, 2026, at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference c.
Allspring Global Investments Holdings LLC increased its stake in shares of Novanta Inc. (NASDAQ: NOVT) by 75.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,399,462 shares of the technology company's stock after purchasing an additional 604,055
Congress Asset Management Co. raised its stake in Novanta Inc. (NASDAQ: NOVT) by 3.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 611,978 shares of the technology company's stock after buying an additional 21,331 shares during the quarter. Congress
BOSTON--(BUSINESS WIRE)--Novanta Inc. (NASDAQ: NOVT) announced today that it has joined NVIDIA Halos AI Systems Inspection Lab, the first ANSI National Accreditation Board (ANAB) accredited inspection lab for AI-driven physical systems. The lab helps accelerate certification and advance trust in key components and subsystems enabling the next generation of robotics and physical AI systems. By participating in Halos AI Systems Inspection Lab, Novanta will work with NVIDIA to validate the interop.
Capital International Investors reduced its stake in shares of Novanta Inc. (NASDAQ: NOVT) by 82.2% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 134,552 shares of the technology company's stock after selling 620,843 shares during the quarter. Capital
Blair William and Co. IL lessened its holdings in Novanta Inc. (NASDAQ: NOVT) by 48.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 132,427 shares of the technology company's stock after selling 126,931 shares during the period. Blair William
